Home24H • FRA
add
Hansa Biopharma AB
Previous close
€3.80
Day range
€3.67 - €3.67
Year range
€1.73 - €3.79
Market cap
4.07B SEK
Avg Volume
788.00
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 75.99M | 134.99% |
Operating expense | 176.25M | -11.69% |
Net income | -165.04M | 40.40% |
Net profit margin | -217.19 | 74.64% |
Earnings per share | -1.62 | 60.29% |
EBITDA | -124.28M | 30.99% |
Effective tax rate | -0.24% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 701.08M | 72.99% |
Total assets | 1.17B | 45.73% |
Total liabilities | 1.25B | -10.04% |
Total equity | -84.13M | — |
Shares outstanding | 101.76M | — |
Price to book | -4.57 | — |
Return on assets | -32.74% | — |
Return on capital | -51.50% | — |
Cash Flow
Net change in cash
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -165.04M | 40.40% |
Cash from operations | -177.54M | -20.12% |
Cash from investing | — | — |
Cash from financing | 627.58M | 33,553.04% |
Net change in cash | 449.01M | 402.85% |
Free cash flow | -7.84M | 94.69% |
About
Founded
2007
Website
Employees
125